Company Filing History:
Years Active: 1998
Title: Ken Davis: Innovator in Nucleic Acid Ligands
Introduction
Ken Davis is a notable inventor based in Los Altos, CA. He has made significant contributions to the field of flow cytometry through his innovative use of nucleic acid ligands. With a total of 3 patents, his work has advanced diagnostic applications in medical science.
Latest Patents
One of Ken's latest patents involves the use of high-affinity oligonucleotide ligands in flow cytometry diagnostic applications. This invention discloses DNA ligands that have one or more fluorophore molecules attached, which are particularly useful in flow cytometry. Another significant patent focuses on high-affinity oligonucleotide ligands to chorionic gonadotropin hormone. This patent describes methods for identifying and preparing nucleic acid ligands to CG-related glycoprotein hormones, including specific RNA ligands to hCG and hTSH identified by the SELEX method.
Career Highlights
Throughout his career, Ken has worked with prominent companies such as Nexstar Pharmaceuticals, Inc. and Gilead Sciences, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and diagnostics.
Collaborations
Ken has collaborated with notable professionals in his field, including Sumedha D Jayasena and Larry M Gold. These collaborations have further enriched his research and innovations.
Conclusion
Ken Davis is a distinguished inventor whose work in nucleic acid ligands has made a significant impact on flow cytometry and diagnostic applications. His contributions continue to influence the field and pave the way for future innovations.